XML 20 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance, common stock (in shares) at Mar. 31, 2019   53,670,000        
Beginning balance, treasury stock (in shares) at Mar. 31, 2019       1,871,000    
Beginning balance at Mar. 31, 2019 $ 1,095,831 $ 536 $ 479,150 $ (59,928) $ (25,747) $ 701,820
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation $ 7,644   7,644      
Exercise of stock options (in shares) 47,900 48,000        
Exercise of stock options $ 1,324 $ 1 1,323      
Issuance of shares related to restricted stock (in shares)   87,000        
Issuance of shares related to restricted stock 0 $ 1 (1)      
Treasury share repurchases (in shares)       1,848,000    
Treasury share repurchases (57,695)     $ (57,695)    
Net income 142,281         142,281
Other comprehensive (loss) income (18,414)       (18,414)  
Ending balance, common stock (in shares) at Mar. 31, 2020   53,805,000        
Ending balance, treasury stock (in shares) at Mar. 31, 2020       3,719,000    
Ending balance at Mar. 31, 2020 1,170,971 $ 538 488,116 $ (117,623) (44,161) 844,101
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation $ 8,543   8,543      
Exercise of stock options (in shares) 119,600 120,000        
Exercise of stock options $ 2,851 $ 1 2,850      
Issuance of shares related to restricted stock (in shares)   74,000        
Issuance of shares related to restricted stock 0 $ 1 (1)      
Treasury share repurchases (in shares)       369,000    
Treasury share repurchases (13,109)     $ (13,109)    
Net income 164,682         164,682
Other comprehensive (loss) income $ 24,360       24,360  
Ending balance, common stock (in shares) at Mar. 31, 2021   53,999,000        
Ending balance, treasury stock (in shares) at Mar. 31, 2021 4,088,000     4,088,000    
Ending balance at Mar. 31, 2021 $ 1,358,298 $ 540 499,508 $ (130,732) (19,801) 1,008,783
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation $ 9,039   9,039      
Exercise of stock options (in shares) 226,000.0 226,000        
Exercise of stock options $ 7,040 $ 2 7,038      
Issuance of shares related to restricted stock (in shares)   205,000        
Issuance of shares related to restricted stock 0 $ 2 (2)      
Treasury share repurchases (in shares)       63,000    
Treasury share repurchases (2,916)     $ (2,916)    
Net income 205,381         205,381
Other comprehensive (loss) income $ 769       769  
Ending balance, common stock (in shares) at Mar. 31, 2022   54,430,000        
Ending balance, treasury stock (in shares) at Mar. 31, 2022 4,151,000     4,151,000    
Ending balance at Mar. 31, 2022 $ 1,577,611 $ 544 $ 515,583 $ (133,648) $ (19,032) $ 1,214,164